There is a great deal of information regarding the minimal requirements for activation of primed T cells. T cell clones can be stimulated to release granule contents and produce lymphokines by anti-CD3 antibody or purified antigen-MHC proteins. T cell hybridomas can also be stimulated to produce lymphokines by anti-CD3 antibody or purified antigen-MHC proteins. Activation of these primed T cell lines can occur in the absence of specialized presenting cells and their accessory molecules. This project is to define the minimal requirements for activation of naive T cells and to evaluate the effects of additional stimuli on the magnitude and type of T cell activation elicited . We plan on evaluating the activation of naive T cells using different activators such as: anti-CD3 antibody, mitogens and purified allo-MHC molecules . We plan on evaluating different T cell activation parameters (lymphokine production, anergy induction, signal transduction and gene expression) in this system. We will then evaluate changes in these T cell responses caused by the addition of lymphokines, adhesion molecules or costimulatory molecules to the primary T cell stimulus.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BO003006-01
Application #
3748254
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost